N-acetylcysteine (NAC) may help reduce miscarriage risk primarily by combating oxidative stress, a condition where harmful molecules overwhelm the body’s defenses and damage cells critical to maintaining a pregnancy. NAC is a precursor to glutathione, one of the body’s most important antioxidants, and its protective effects appear to work through several overlapping biological pathways. The evidence is promising but still limited, with most research coming from animal studies and small clinical trials.
Oxidative Stress and Pregnancy Loss
Pregnancy naturally increases oxidative stress in the body. In a healthy pregnancy, antioxidant defenses keep this in check. But when the balance tips too far, reactive oxygen species (essentially unstable molecules that damage cells) can trigger a cascade of problems: damaged placental tissue, impaired blood flow to the embryo, and inflammatory responses that disrupt the pregnancy. This oxidative imbalance has been linked to recurrent unexplained pregnancy loss.
NAC works by boosting your body’s production of glutathione, a molecule that neutralizes these harmful reactive oxygen species before they cause damage. It also enhances the activity of enzymes involved in glutathione metabolism, effectively strengthening your body’s built-in antioxidant system rather than just adding an external antioxidant on top.
Reducing Placental Inflammation
Excessive inflammation in the placenta and uterus is one of the key ways oxidative stress leads to pregnancy loss. NAC appears to dial down this inflammation through a specific mechanism: it inhibits something called the NLRP3 inflammasome, a protein complex inside cells that acts like an alarm system, triggering the release of inflammatory signals. When this system is overactive, it floods the placenta with inflammatory molecules.
Animal research has shown that NAC supplementation significantly reduced levels of multiple inflammatory signals in both the placenta and maternal blood, including IL-1β, IL-18, IL-6, and IL-8. It also reduced the infiltration of immune cells into the placenta. NAC achieves this partly by blocking the activity of NF-κB, a master switch for inflammation that gets turned on by signals like TNF-α and IL-1β. By keeping this switch in the “off” position, NAC helps prevent the kind of runaway inflammation that can compromise a pregnancy.
Improving Uterine Receptivity and Implantation
For a pregnancy to succeed, the embryo needs to attach firmly to the uterine lining, and the lining itself needs to undergo a transformation called decidualization to support the growing embryo. NAC appears to support both of these processes.
Research in animal models has found that NAC improves the receptivity and decidualization of the uterus and enhances gene expression related to placental development. Several biological pathways related to cell adhesion were more active in NAC-treated subjects, suggesting the supplement could help the embryo attach more securely to the uterine wall. Poor attachment is one cause of very early pregnancy loss, sometimes before a person even knows they’re pregnant.
NAC also promotes the health of granulosa cells, which surround and nourish developing eggs in the ovaries. By reducing oxidative damage and cell death in these cells, NAC supports healthier follicle development, which can contribute to better egg quality and, downstream, a more viable embryo.
NAC and PCOS-Related Pregnancy Loss
Women with polycystic ovary syndrome face higher rates of both infertility and miscarriage, partly due to insulin resistance and elevated androgen levels. NAC has been studied specifically in this population because of its ability to improve how insulin receptors function. When insulin works more efficiently, circulating insulin levels drop, which in turn lowers testosterone and free androgen levels. This hormonal rebalancing can create a more favorable environment for pregnancy.
A systematic review of randomized controlled trials found that women with PCOS who took NAC had higher odds of achieving a live birth, getting pregnant, and ovulating compared to those taking a placebo. However, the same review found no significant difference in miscarriage rates between the NAC and placebo groups, with considerable variation between individual studies. So while NAC clearly helps PCOS patients get pregnant, its specific role in preventing miscarriage once pregnancy is established in this group remains unclear.
A separate meta-analysis comparing NAC to metformin (the standard treatment for insulin resistance in PCOS) found that NAC significantly reduced BMI and total testosterone but showed no significant difference in pregnancy rates between the two. The authors concluded NAC may serve as an alternative supplement to metformin, though larger trials are needed.
What the Clinical Evidence Shows
The strongest mechanistic evidence for NAC preventing miscarriage comes from animal and cell studies, which consistently show reduced oxidative damage, lower inflammation, and improved uterine conditions. Human clinical trials are fewer and smaller. One study on recurrent unexplained pregnancy loss noted that NAC’s antioxidant effect could suppress the oxidative stress cascade associated with pregnancy wastage, but large, well-designed trials confirming a direct reduction in miscarriage rates are still lacking.
A randomized controlled trial published in the American Journal of Obstetrics and Gynecology found that NAC administration during pregnancy was practically feasible and safe, with no increase in neonatal complications. NAC did reach fetal circulation, where it correlated with levels of cysteine and related compounds, but it did not significantly alter the fetal inflammatory profile or red blood cell glutathione levels in that particular study context.
Safety During Pregnancy
NAC has a long track record as a safe medication outside of pregnancy. It’s widely used as a mucolytic (to break up mucus) and as the standard treatment for acetaminophen overdose, including in pregnant patients. Clinical trial data has not identified increased risks of adverse events for mother or baby. That said, most pregnancy-specific safety data comes from studies conducted in the second and third trimesters. First-trimester data is more limited, which is significant since that’s when most miscarriages occur and when someone hoping to prevent pregnancy loss would most want to start supplementation.
The dosages used in studies vary, and no standardized protocol for miscarriage prevention has been established. Without consistent dosing guidelines from large trials, the optimal amount and timing of NAC for this specific purpose remains an open question.